AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.080
-0.010 (-0.92%)
At close: Oct 31, 2024, 4:00 PM
1.100
+0.020 (1.85%)
After-hours: Oct 31, 2024, 4:00 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $32.23 million as of October 31, 2024. Its market cap has decreased by -89.89% in one year.
Market Cap
32.23M
Enterprise Value
-72.01M
1-Year Change
-89.89%
Ranking
Category
Stock Price
$1.08
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $32.23M, a decrease of -88.53%. That is a compound annual growth rate of -56.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2024 | 32.50M | -94.67% |
| Dec 29, 2023 | 609.40M | 229.58% |
| Dec 30, 2022 | 184.90M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 33.43M |
| Nortech Systems | 33.42M |
| Daré Bioscience | 33.42M |
| Singular Genomics Systems | 33.24M |
| KALA BIO | 33.13M |
| IceCure Medical | 32.68M |
| Iterum Therapeutics | 32.47M |
| Concord Medical Services Holdings | 32.35M |